Advertisement

Molecular Biosystems: The San Diego-based firm reported...

Share

Molecular Biosystems: The San Diego-based firm reported a $1.9-million first-quarter profit on revenue of $5.9 million, up from a profit of $231,242 on revenue of $1.5 million for the same three months last year.

The company, which to date has had minimal products sales, attributed the revenue and profits largely to non-recurring license fees generated by its Albunex ultrasound-imaging agent still in development. Albunex is being clinically tested and could be on the market in 1990 if the tests are successful.

Advertisement